Traders bought the NKE stock dip and now there is a chance the rally will continue. Profit from the potential in Nike with room to spare. More
Abbott Laboratories (ABT) a Buy on Strong Earnings Momentum
The current recommendation of Buy for Abbott Laboratories (NYSE:ABT) has been derived by using Louis Navellier's investing methods and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking ABT has had from Portfolio Grader for 3 months. More
There Still Isn’t Any Reason To Buy Fitbit Inc Stock
Even in a best case scenario, FIT stock isn't undervalued; in all other scenarios, the stock is way overvalued. More
Buy Costco Wholesale Corporation While It’s Down
Bargain shopping in Costco may be hard to come by, but a bullish modified spread in COST stock looks well-priced in front of earnings. More
Wilting Quant Score Drops Toronto-Dominion Bank (TD) to Hold
Toronto-Dominion Bank (NYSE:TD) is one of the 760 companies in the GICS Financials sector, and a constituent of the 341 company Banks GICS industry group within this sector. TD's market value is $104.2 billion which falls in the top decile in its industry group. Portfolio Grader's current ranking for TD puts it 118 among the 341 companies in this industry group, giving it an above-average position; in the top half of the sector with a ranking of 288 among the 760 companies in the sector, and number 1,900 in the nearly 5,000 company Portfolio Grader universe. More
Tuesday’s Vital Data: Tesla Inc (TSLA), Apple Inc. (AAPL) and Valeant Pharmaceuticals International, Inc. (VRX)
Tesla (TSLA) Model 3s at distribution centers, Apple (AAPL) options rise on Shazam and Valeant launches Vyzulta, eyes FDA on Luminesse. More
Banco Santander’s (SAN) Robust Quant Score Keep it a Buy
The current recommendation of Buy for Banco Santander SA (NYSE:SAN) is the result of using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing system. SAN has maintained this ranking for 2 months. More
